- Home
- Life Sciences
- Pharmaceutical
- Pharmaceutical Analysis & Statistics, March 2013 (p30)
Talk to Robyn
00 1 718 213 49 04
Search inside this page
Top countries
- United States (6 302)
- World (14 351)
- China (1 130)
- Japan (1 781)
- Germany (1 281)
-
- India (910)
- Europe (1 290)
- France (1 212)
- Canada (845)
- Italy (1 173)
- Spain (1 149)
- United Kingdom (1 255)
- Australia (651)
- South Korea (504)
- Sweden (406)
- Switzerland (398)
- Israel (437)
- Netherlands (402)
- Denmark (345)
- Norway (304)
Publication dates
Publishers
- Global Data (6 560)
- Global Markets Direct (7 032)
- GenericsWeb - Selector 7 (394)
- Generics Web - Selector 44 (394)
- GenericsWeb (348)
-
- Bioseeker (472)
- Euromonitor International (793)
- Business Monitor International (45 323)
- Global Research & Data Services (551)
- MarketLine (881)
- Asia Market Information & Development Company (113)
- Ibisworld (45)
- Infiniti Research Limited (88)
- GBI Research (231)
- Timetric (34)
- Currentpartnering (259)
- Greystone Research Associates (41)
- World Market Intelligence Ltd (137)
- Barnes Reports (37)
- Canadean Ltd (62)
- ICD Research (353)
- Transparency Market Research (20)
- Access China Management Consulting Ltd. (17)
- BCC Research (100)
- Firstword Pharma (35)
- Emerging Markets Direct Media Holdings (26)
- Global Industry Analysts (4)
- MarketsandMarkets (33)
- Research In China (31)
- Visiongain (130)
- Aruvian's R'search (148)
- Daedal Research (24)
- Espicom Business Intelligence (222)
- KnowMade (2)
- La Merie Publishing (95)
- Mintel (319)
- PMR Ltd. (32)
- RNCOS (51)
- TriMark Publications (20)
- Asianet-Pakistan (5)
- Axis Research Mind (1)
- CCM International Limited (25)
- Euroresearch & Consulting (1)
- Huidian Research (10)
- International Market Analysis Research and Consult (14)
- Koncept Analytics (120)
- MarketLine Industry Guides (20)
- Pacific Bridge Medical (15)
- Chinascope Financial (4)
- Life Science Analytics (LSA) (2 463)
- Datamonitor (1 245)
- Frost & Sullivan (186)
- SCRIP Insights (120)
- Global Industry Analyst (118)
- Obainfo (116)
- Business Review (92)
- Urch Publishing (85)
- Timely Data Resources Inc. (83)
- Kalorama Information (70)
- CHI Insight Pharma Reports (56)
- Venture Planning Group (44)
- ABMRG (33)
- VacZine Analytics Group Of Assay Advantage Ltd (28)
- DrugPatentWatch - ThinkBiotech LLC (27)
- The Assessment Group (19)
- Ken Research Private (18)
- Freedonia (17)
- Beijing Zeefer Consulting Ltd (16)
- BioPharm Reports (16)
- Plimsoll Publishing Ltd UK (16)
- IData Research, Inc. (16)
- Apollo Managed Care Consultants (13)
- Arrowhead (13)
- SeeNews - Research & Profiles (13)
- Renub Research (12)
- Arena (11)
- Cygnus Business Consulting and Research (10)
- Sociable Pharma (10)
- Databank - Cerved Group (9)
- Packaged Facts (9)
- Netscribes (India) Pvt. Ltd. (8)
- Grey House Publishing (7)
- Lucintel (5)
- The Economist Intelligence Unit (5)
- Beremans Ltd (4)
- IPEXL (4)
- IndexBox Marketing (4)
- Leatherhead Food Research (4)
- Verdict Research Ltd (4)
- Analytiqa (3)
- Beijing HuaJing Ltd (3)
- Cientifica ltd (3)
- Key Note Publications Ltd (3)
- Red Mountain Insights (3)
- Smithers Rapra Technology Ltd (3)
- Zzz- Median Conseil (3)
- BioInformatics (2)
- BusinesStat (2)
- France Innovation Scientifique et Transfert (2)
- Zzz- Sokrat Capital Ltd (2)
All regions
-
- Algeria (258)
- Angola (240)
- Benin (230)
- Botswana (241)
- Burkina Faso (230)
- Burundi (230)
- Cameroon (245)
- Cape Verde (228)
- Central African Republic (26)
- Chad (231)
- Comoros (209)
- Congo, Democratic Republic Of (267)
- Djibouti (233)
- Egypt (373)
- Equatorial Guinea (224)
- Eritrea (224)
- Ethiopia (236)
- Gabon (238)
- Gambia (230)
- Ghana (255)
- Guinea (685)
- Guinea Bissau (230)
- Ivory Coast (cote D'ivoire) (3)
- Kenya (257)
- Lesotho (211)
- Liberia (212)
- Libyan Arab Jamahiriya (235)
- Madagascar (230)
- Malawi (231)
- Mali (231)
- Mauritania (226)
- Mauritius (231)
- Morocco (267)
- Mozambique (242)
- Namibia (241)
- Niger (230)
- Nigeria (280)
- Rwanda (230)
- Sao Tome and Principe (206)
- Senegal (235)
- Seychelles (226)
- Sierra Leone (231)
- Somalia (216)
- South Africa (436)
- Sudan (252)
- Swaziland (230)
- Tanzania (248)
- Togo (226)
- Tunisia (242)
- Uganda (244)
- Zambia (241)
- Zimbabwe (245)
-
- Afghanistan (233)
- Armenia (240)
- Azerbaijan (252)
- Bahrain (249)
- Bangladesh (257)
- Bhutan (217)
- Brunei Darussalam (230)
- Cambodia (243)
- China (1 130)
- Georgia (257)
- India (910)
- Indonesia (335)
- Iran (321)
- Iraq (233)
- Israel (437)
- Japan (1 781)
- Jordan (252)
- Kazakhstan (328)
- Kuwait (252)
- Kyrgyz Republic (kyrgyzstan) (238)
- Laos (230)
- Lebanon (14)
- Malaysia (305)
- Maldives (220)
- Mongolia (31)
- Myanmar (231)
- Nepal (225)
- North Korea (28)
- Oman (321)
- Pakistan (278)
- Philippines (330)
- Qatar (243)
- Saudi Arabia (295)
- Singapore (348)
- South Korea (504)
- Sri Lanka (250)
- Syrian Arab Republic (235)
- Taiwan (126)
- Tajikistan (228)
- Thailand (314)
- Turkey (56)
- Turkmenistan (26)
- United Arab Emirates (277)
- Uzbekistan (254)
- Vietnam (280)
- Yemen (235)
-
- Albania (233)
- Andorra (196)
- Austria (296)
- Belarus (262)
- Belgium (336)
- Bosnia and Herzegovina (240)
- Bulgaria (358)
- Croatia (341)
- Cyprus (234)
- Czech Republic (388)
- Denmark (345)
- Estonia (314)
- Finland (281)
- France (1 212)
- Germany (1 281)
- Greece (349)
- Hungary (353)
- Iceland (235)
- Ireland (371)
- Italy (1 173)
- Latvia (328)
- Liechtenstein (1)
- Lithuania (271)
- Luxembourg (234)
- Macedonia (42)
- Malta (225)
- Moldova, Republic Of (309)
- Monaco (172)
- Netherlands (402)
- Norway (304)
- Poland (393)
- Portugal (282)
- Romania (379)
- Russian Federation (573)
- San Marino (186)
- Serbia and Montenegro (332)
- Slovakia (slovak Republic) (304)
- Slovenia (315)
- Spain (1 149)
- Sweden (406)
- Switzerland (398)
- Ukraine (354)
- United Kingdom (1 255)
-
- Antigua and Barbuda (215)
- Bahamas (233)
- Barbados (235)
- Belize (286)
- Canada (845)
- Costa Rica (61)
- Cuba (225)
- Dominica (441)
- Dominican Republic (247)
- El Salvador (308)
- Grenada (215)
- Guatemala (315)
- Haiti (223)
- Honduras (310)
- Jamaica (232)
- Mexico (462)
- Nicaragua (308)
- Panama (13)
- Saint Kitts & Nevis (213)
- Saint Lucia (233)
- United States (6 302)
-
- Argentina (400)
- Australia (651)
- Brazil (542)
- Canada (845)
- China (1 130)
- France (1 212)
- Germany (1 281)
- India (910)
- Indonesia (335)
- Italy (1 173)
- Japan (1 781)
- Mexico (462)
- Russian Federation (573)
- Saudi Arabia (295)
- South Africa (436)
- South Korea (504)
- Turkey (56)
- United Kingdom (1 255)
- United States (6 302)
-
- Australia (651)
- Austria (296)
- Belgium (336)
- Canada (845)
- Chile (346)
- Czech Republic (388)
- Denmark (345)
- Estonia (314)
- Finland (281)
- France (1 212)
- Germany (1 281)
- Greece (349)
- Hungary (353)
- Iceland (235)
- Ireland (371)
- Israel (437)
- Italy (1 173)
- Japan (1 781)
- Luxembourg (234)
- Mexico (462)
- Netherlands (402)
- New Zealand (291)
- Norway (304)
- Poland (393)
- Portugal (282)
- Slovenia (315)
- South Korea (504)
- Spain (1 149)
- Sweden (406)
- Switzerland (398)
- Turkey (56)
- United Kingdom (1 255)
- United States (6 302)
data types
Free Market Research Guides to Download
Pharmaceutical Analysis & Statistics, March 2013 (p30)
You might be interested in: therapeutics, cancer, drug, more »
» Purchase Premium Reports
871-910 of about 26 000 reports
Metabolic Disorders - Pipeline Review, H1 2013
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
Metabolic Disorders - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Metabolic Disorders - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report ...
- Industries : Pathology
- Countries : World
World Pathology: Diabetic Neuropathy - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Diabetic Neuropathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : World, United States, Sweden
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2013
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2013', provides an overview ...
- Industries : Pathology
- Countries : United States, World
World Therapy: Postherpetic Neuralgia - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Postherpetic Neuralgia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Therapy
- Countries : World
World Therapy: Chemotherapy Induced Anemia - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Chemotherapy Induced Anemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...
- Industries : Therapy
- Countries : World, United States
World Therapy: Alopecia - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Alopecia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...
- Industries : Therapy
- Countries : World
Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2013
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2013', provides an overview ...
- Industries : Pathology
- Countries : Canada, World
World Pathology: Smallpox - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Smallpox, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...
- Industries : Drug and Medication
- Countries : United States, World
Therapy in United States: Renal Anemia - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Renal anemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Therapy
- Countries : United States, World, Japan
Nonhematologic Malignancy - Pipeline Review, H1 2013
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
Nonhematologic Malignancy - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Nonhematologic Malignancy - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. ...
- Industries : Therapy
- Countries : World
Chronic Back Pain - Pipeline Review, H1 2013
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
Chronic Back Pain - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Chronic Back Pain - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report ...
- Industries : Pathology
- Countries : United States, World
Severe Psoriasis - Pipeline Review, H1 2013
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
Severe Psoriasis - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Severe Psoriasis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report ...
- Industries : Therapy
- Countries : World
Non-Small Cell Lung Carcinoma - Pipeline Review, H1 2013
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
Non-Small Cell Lung Carcinoma - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Non-Small Cell Lung Carcinoma - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic ...
- Industries : Pathology
- Countries : United States
World Drug and Medication: Polio - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Polio, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the ...
- Industries : Drug and Medication
- Countries : World
Drug Discovery and Development in United States: Dyskinesia - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Dyskinesia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Therapy
- Countries : World, United States
World Drug and Medication: Dermatitis - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Dermatitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : China
World Pathology: Psoriatic Arthritis - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Psoriatic Arthritis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : World, Indonesia
World Drug and Medication: Tetanus - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Tetanus, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...
- Industries : Drug and Medication
- Countries : Japan, World, United States, Australia
World Drug and Medication: Opium (Opioid) Addiction - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Opium (Opioid) Addiction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Drug and Medication
- Countries : World, United States
World Pathology: Pertussis - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Pertussis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Drug and Medication
- Countries : Japan, World
Drug and Medication in Sweden: Type 1 Diabetes (Juvenile Diabetes) ? Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Type 1 Diabetes (Juvenile Diabetes), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...
- Industries : Pathology
World Pathology: Diabetic Foot Ulcers - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Diabetic Foot Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : World, United States
World Pathology: Candidiasis - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Candidiasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : United States, World
Therapy in United States: Cough - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Cough, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the ...
- Industries : Therapy
- Countries : World, Australia
Colitis - Pipeline Review, H1 2013
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
Colitis - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Colitis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...
- Industries : Pathology
- Countries : World
World Pathology: Actinic Keratosis - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Actinic Keratosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : World, Austria, Netherlands
World Therapy: Lupus Nephritis - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Lupus Nephritis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : World
World Pathology: Constipation - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Constipation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : World
World Biological Therapy: Amyloidosis - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Amyloidosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : World, United States
World Therapy: Macular Edema - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Macular Edema, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Therapy
- Countries : Taiwan, World
Algeria Poisonings, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Algeria
Guyana Poisonings, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Guyana
South Korea Poisonings, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : South Korea
Belarus Poisonings, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Belarus
Mauritius Poisonings, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Mauritius
Import Amount-pharmaceuticals-china-annual, In Usd (ten Thousands)
- $ 250
- Industry data
- May 2013
Yearly, From 2000 To 2011
By Chinascope Financial
Source: Chinascope Financial
- Industries : Pharmaceutical
Import Volume-pharmaceuticals-china-annual, In Tonne (units)
- $ 250
- Industry data
- May 2013
Yearly, From 1996 To 2011
By Chinascope Financial
Source: Chinascope Financial
- Industries : Pharmaceutical
Export Volume-pharmaceuticals-china-annual, In Tonne (units)
- $ 250
- Industry data
- May 2013
Yearly, From 2000 To 2011
By Chinascope Financial
Source: Chinascope Financial
- Industries : Pharmaceutical
Export Amount-pharmaceuticals-china-annual, In Usd (ten Thousands)
- $ 250
- Industry data
- May 2013
Yearly, From 2000 To 2011
By Chinascope Financial
Source: Chinascope Financial
- Industries : Pharmaceutical
Albania Poisonings, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Albania
» Download Public Reports
About 42 000 reports
Export (harmonized System): Pharmaceutical Products
- Industry data
- April 2013
Monthly, From 1992 To 2013
Source: U.S. Department of Labor: Bureau of Labor Statistics
U.s. Vitamin D Sector Analysis
May 2013Vaccine Market In Tanzania
May 2013The Swazi Pharmaceutical Industry
May 2013U.s. Pharmaceutical Industry
May 2013» Read our Company Profiles
About 600 CompaniesGlaxoSmithKline P.L.C.
United StatesNovartis Inc.
SwitzerlandGlaxoSmithKline PLC
United KingdomPfizer Inc.
United StatesJohnson and Johnson
United StatesReportlinker.com © Copyright 2013. All rights reserved.
